Identifying small molecules that induce the expression DNAJB3 or recapitulate its function could be leveraged as a possible novel strategy for the control and management of metabolic defects leading to IR and type 2 diabetes. The gene discussed is DNAJB3; the disease is type 2 diabetes mellitus.